Moderna's mRNA vaccine reduces the recurrence of skin cancer in a clinical trial. wapo.st/4gosZtG
Cancer treatment could face landmark moment with promising vaccine
A therapy using the same mRNA technology in coronavirus vaccines showed positive results in trial for skin cancer patients, drugmakers Moderna and Merck said.
wapo.st